← Back to Clinical Trials
Recruiting NCT06118528

NCT06118528 EAT: A Reliable Eating Assessment Technology for Free-living Individuals

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06118528
Status Recruiting
Phase
Sponsor Northwestern University
Condition Wearable Electronic Device
Study Type INTERVENTIONAL
Enrollment 72 participants
Start Date 2024-09-04
Primary Completion 2026-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Blur ObfuscationCartoon ObfuscationEdge Obfuscation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 72 participants in total. It began in 2024-09-04 with a primary completion date of 2026-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study utilizes a small, privacy-conscious wearable device intended to monitor human behaviors. The device is worn around the neck, capturing the wearer's head and upper torso within its field of view, and records color images without audio. Participants visit the lab for consent, device training and recording of several activities using the device. Participants will then take the device home and wear it during their normal schedules for four "active" weeks. During each active week, participants will wear the device, keep a log of all food and drink items consumed throughout the day and participate in unscheduled phone calls with a dietitian. A "washout" week occurs in between each active week in which participants do not need to complete any study tasks. Alongside the device, we have included three privacy filters (blur, edge, and avatar) capable of obscuring faces and objects seen in the device-captured images. All participants will be subject to unfiltered recording during their first week followed by a different filter each following active week in a random order. At the start of each active week, participants view an example of what their recorded images will look like that week (given the privacy filter). At the end of the seven weeks, participants will return the device and provide the lab with feedback on the design of the device and its privacy-preserving features.

Eligibility Criteria

Inclusion Criteria: * BMI greater than or equal to 18.5 * Chicago metropolitan area resident * Able to speak, read and write in English * Has a valid phone number * Owns a smartphone * Has access to a computer Exclusion Criteria: * Pregnant or breastfeeding individuals * Experienced significant weight loss/gain in the last three months (25 lbs or more) * Diagnosed with or has a family history of genetic obesity syndromes (e.g., Prader-Willi, Bardet-Biedl, Cohen Syndrome) * Member of household enrolled in the study

Contact & Investigator

Central Contact

Nabil Alshurafa

✉ nabil@northwestern.edu

📞 3125034517

Frequently Asked Questions

Who can join the NCT06118528 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Wearable Electronic Device. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06118528 currently recruiting?

Yes, NCT06118528 is actively recruiting participants. Contact the research team at nabil@northwestern.edu for enrollment information.

Where is the NCT06118528 trial being conducted?

This trial is being conducted at Chicago, United States.

Who is sponsoring the NCT06118528 clinical trial?

NCT06118528 is sponsored by Northwestern University. The trial plans to enroll 72 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology